European journal of cancer (Oxford, England : 1990)HumansPancreatic NeoplasmsMaleFemaleReceptors
Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer.
R L Eefsen, I J Christensen, A Z Johansen, I M Chen, D Calatayud, P Pfeiffer, F Andersen, J S Johansen, G Høyer-Hansen
Published: 202510.1016/j.ejca.2025.116095
Abstract
PURPOSE: Different forms of urokinase plasminogen activator receptor (uPAR) in tissues and plasma are associated with poor prognosis in several types of cancers. This study aimed to determine whether different forms of soluble uPAR (suPAR) in pretrea…
Preview only. Read the full abstract at the source